223 related articles for article (PubMed ID: 31396640)
1. [Is there a magic bullet for sarcomas? : Personalised treatment for maligant tumours of bone and soft tissue].
Scheipl S; Liegl-Atzwanger B; Szkandera J; Rinner B; Viertler C; Friesenbichler J; Bergovec M; Leithner A
Orthopade; 2019 Sep; 48(9):776-783. PubMed ID: 31396640
[TBL] [Abstract][Full Text] [Related]
2. [Molecular biology of sarcoma and therapeutic choices].
Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
[TBL] [Abstract][Full Text] [Related]
3. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
Nakano K; Takahashi S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
[TBL] [Abstract][Full Text] [Related]
4. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
Sethi TK; Keedy VL
Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
[TBL] [Abstract][Full Text] [Related]
5. [Targeted therapy of sarcomas].
Cassier PA; Dufresne A; El Sayadi H; Pissaloux D; Alberti L; Decouvelaere AV; Ranchere D; Ray-Coquard I; Blay JY
Bull Cancer; 2008 Oct; 95(10):963-74. PubMed ID: 19004727
[TBL] [Abstract][Full Text] [Related]
6. Opportunities for improving the therapeutic ratio for patients with sarcoma.
Wunder JS; Nielsen TO; Maki RG; O'Sullivan B; Alman BA
Lancet Oncol; 2007 Jun; 8(6):513-24. PubMed ID: 17540303
[TBL] [Abstract][Full Text] [Related]
7. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
8. Sarcoma.
Skubitz KM; D'Adamo DR
Mayo Clin Proc; 2007 Nov; 82(11):1409-32. PubMed ID: 17976362
[TBL] [Abstract][Full Text] [Related]
9. Management of sarcomas of the head and neck.
Brockstein B
Curr Oncol Rep; 2004 Jul; 6(4):321-7. PubMed ID: 15161589
[TBL] [Abstract][Full Text] [Related]
10. [Systemic therapy of sarcomas : New biomarkers and therapeutic strategies].
Bauer S; Dirksen U; Schildhaus HU
Pathologe; 2019 Jul; 40(4):436-442. PubMed ID: 31243550
[TBL] [Abstract][Full Text] [Related]
11. Targeted therapies in soft tissue sarcomas.
Judson I
Ann Oncol; 2010 Oct; 21 Suppl 7():vii277-80. PubMed ID: 20943628
[TBL] [Abstract][Full Text] [Related]
12. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
13. Novel Aspects of Genetics, Molecular Biology and Clinical Oncology of Sarcomas.
Houfková K; Hatina J
Klin Onkol; 2020; 33(1):66-78. PubMed ID: 32075391
[TBL] [Abstract][Full Text] [Related]
14. Comparison between preoperative biopsy and post-excision histology results in sarcoma: experience at Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
Panda KG; Hale MJ; Kruger D; Luvhengo TE
S Afr J Surg; 2014 Jun; 52(2):45-8. PubMed ID: 25216095
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
16. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic dissemination of bone and soft tissue sarcomas: a lymphographic investigation.
Tallroth K
Acta Radiol Suppl; 1976; 349():1-84. PubMed ID: 206099
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies for sarcomas: new roles for the pathologist.
Al-Zaid T; Somaiah N; Lazar AJ
Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526
[TBL] [Abstract][Full Text] [Related]
19. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
Kopp HG; Patel S; Brücher B; Hartmann JT
Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
[TBL] [Abstract][Full Text] [Related]
20. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
Bastiaannet E; Groen H; Jager PL; Cobben DC; van der Graaf WT; Vaalburg W; Hoekstra HJ
Cancer Treat Rev; 2004 Feb; 30(1):83-101. PubMed ID: 14766127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
